AGP Picks
View all

Science Press Releases
Provided by AGP

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on August 7, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug. 7, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Aug. 7, 2026

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Hawkins, Inc. to Participate in Seaport Research Partners’ 15th Annual Summer Investor Conference
Aug. 7, 2026

Hawkins, Inc. to Participate in Seaport Research Partners’ 15th Annual Summer Investor Conference

Indeterminate GlobeNewswire
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
Aug. 7, 2026

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire
aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
Aug. 7, 2026

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Indeterminate GlobeNewswire
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug. 7, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
Aug. 7, 2026

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

Indeterminate GlobeNewswire
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug. 7, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Aeries Technology to Report Financial Results for the Quarter Ended June 30, 2026 on August 10, 2026
Aug. 7, 2026

Aeries Technology to Report Financial Results for the Quarter Ended June 30, 2026 on August 10, 2026

Indeterminate GlobeNewswire
QCI AGI56.1 Now Deployed to Customers Following Successful Rollout
Aug. 7, 2026

QCI AGI56.1 Now Deployed to Customers Following Successful Rollout

Indeterminate GlobeNewswire
U.S. Senate Passes DeOndra Dixon INCLUDE Project Act
Aug. 7, 2026

U.S. Senate Passes DeOndra Dixon INCLUDE Project Act

Indeterminate GlobeNewswire
Carahsoft Showcases Cybersecurity, Defense, Intelligence, AI and Data Innovations at DoDIIS Worldwide 2026, in Tampa, Florida, Aug. 9-12
Aug. 7, 2026

Carahsoft Showcases Cybersecurity, Defense, Intelligence, AI and Data Innovations at DoDIIS Worldwide 2026, in Tampa, Florida, Aug. 9-12

Indeterminate GlobeNewswire
Barrick Announces Senior Appointments to Corporate Affairs and Investor Relations
Aug. 7, 2026

Barrick Announces Senior Appointments to Corporate Affairs and Investor Relations

Indeterminate GlobeNewswire
UPDATE - CurePSP Announces Enrollment of First Participant in the PSP Trial Platform
Aug. 7, 2026

UPDATE - CurePSP Announces Enrollment of First Participant in the PSP Trial Platform

Indeterminate GlobeNewswire
Memocept Announces Official 2026 Launch of Cognitive Function Supplement, Highlighting Ingredient Transparency, Manufacturing Quality, and Consumer Awareness
Aug. 7, 2026

Memocept Announces Official 2026 Launch of Cognitive Function Supplement, Highlighting Ingredient Transparency, Manufacturing Quality, and Consumer Awareness

Indeterminate GlobeNewswire
AdsGram Introduces Telegram Ads Capabilities for Advertisers
Aug. 7, 2026

AdsGram Introduces Telegram Ads Capabilities for Advertisers

Indeterminate GlobeNewswire
Bioinformatics Market to Reach $43.5 Billion by 2030, Driven by AI Integration and Expanding Genomics Applications
Aug. 7, 2026

Bioinformatics Market to Reach $43.5 Billion by 2030, Driven by AI Integration and Expanding Genomics Applications

Indeterminate GlobeNewswire
red violet Announces Closing of $115 Million Underwritten Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option
Aug. 7, 2026

red violet Announces Closing of $115 Million Underwritten Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option

Indeterminate GlobeNewswire
B2Gold Granted Fekola Regional Exploitation Permit by the State of Mali 
Aug. 7, 2026

B2Gold Granted Fekola Regional Exploitation Permit by the State of Mali 

Indeterminate GlobeNewswire
Facility Management Market Surges to $205.36 billion at a CAGR 19.8% by 2032 | Report by MarketsandMarkets™
Aug. 7, 2026

Facility Management Market Surges to $205.36 billion at a CAGR 19.8% by 2032 | Report by MarketsandMarkets™

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.